 | Up a level |
2022
Darr, C., Zschaebitz, S., Niegisch, G., Roghmann, F., Ivanyi, P., Zengerling, F., Paffenholz, P., Biernath, N., Klee, M., Kluemper, N., Tauber, R. L., Hadaschik, B. A., Hilser, T. and Gruenwald, V. (2022). Enfortumab vedotin in metastatic urothelial carcinoma: Retrospective multicentre patient cohort. Ann. Oncol., 33 (7). S. S1342 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2021
Hamacher, R. W., Liu, X., Schuler, M. K., Hentschel, L., Schoffski, P., Kopp, H-G., Bauer, S., Kasper, B., Lindner, L. H., Chemnitz, J-M., Crysandt, M., Stein, A., Steffen, B., Richter, S., Egerer, G., Ivanyi, P., Kunitz, A. and Gruenwald, V. (2021). A post hoc analysis of the EPAZ trial: The prognostic role of geriatric variables in elderly soft tissue sarcoma (STS) patients. Ann. Oncol., 32. S. S1125 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2016
Abbas, M., Steffens, S., Bellut, M., Eggers, H., Grosshennig, A., Becker, J. U., Wegener, G., Schrader, A. J., Gruenwald, V. and Ivanyi, P. (2016). Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC). Med. Oncol., 33 (7). TOTOWA: HUMANA PRESS INC. ISSN 1559-131X